Form 4: Immunic Inc. Director Richard Rudick Acquires 87,300 Shares

Director Richard Rudick purchased 87,300 shares of Immunic Inc. common stock at a price of $1.1497 per share on November 12, 2024.

Summary

• Richard Rudick, a director at Immunic Inc., acquired 87,300 shares of the company's common stock on November 12, 2024.
• The purchase price was $1.1497 per share.
• The transaction was a direct purchase, and the shares are directly owned by Mr. Rudick.

Sentiment

Score: 6

Explanation: The document is neutral in sentiment. It reports a stock purchase by a director, which can be seen as a positive sign, but it's a routine filing and doesn't indicate any major shift in the company's outlook.

Positives

• A director's purchase of shares can be seen as a positive signal of confidence in the company's future prospects.

Industry Context

This is a standard SEC Form 4 filing, which is common for corporate insiders who trade their company's stock. It provides transparency into the trading activities of company directors.

Comparison to Industry Standards

• SEC Form 4 filings are a standard practice for publicly traded companies in the United States.
• The reporting requirements are consistent across all companies and are designed to ensure transparency in insider trading.
• The purchase of shares by a director is a common occurrence and is not unusual.

Stakeholder Impact

• The purchase may have a slightly positive impact on shareholder sentiment, as it indicates confidence from a company director.

Key Dates

Keywords

Immunic Inc., IMUX, Richard Rudick, stock purchase, director, insider trading, SEC Form 4